The relationship between line manager training in mental health and organisational outcomes.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 29 02 2024
accepted: 10 06 2024
medline: 17 7 2024
pubmed: 17 7 2024
entrez: 17 7 2024
Statut: epublish

Résumé

Line manager (LM) training in mental health is gaining recognition as an effective method for improving the mental health and wellbeing of workers. However, research predominantly focuses on the impacts of training at the employee-level, often neglecting the broader organisational-level outcomes. Most studies derive insights from LMs using self-reported data, with very few studies examining impacts on organisational-level outcomes. To explore the relationship between LM training in mental health and organisational-level outcomes using company-level data from a diverse range of organisations. This study is a secondary analysis of anonymised panel survey data from firms in England, with data derived from computer-assisted telephone surveys over four waves (2020, 1899 firms; 2021, 1551; 2022, 1904; and 2023, 1902). The analysis merged the four datasets to control for temporal variations. Probit regression was conducted including controls for age of organisation, sector, size, and wave to isolate specific relationships of interest. We found that LM training in mental health is significantly associated with several organisational-level outcomes, including: improved staff recruitment (β = .317, p < .001) and retention (β = .453, p < .001), customer service (β = .453, p < .001), business performance (β = .349, p < .001), and lower long-term sickness absence due to mental ill-health (β = -.132, p < .05). This is the first study to explore the organisational-level outcomes of LM training in mental health in a large sample of organisations of different types, sizes, and sectors. Training LM in mental health is directly related to diverse aspects of an organisations' functioning and, therefore, has strategic business value for organisations. This knowledge has international relevance for policy and practice in workforce health and business performance.

Sections du résumé

BACKGROUND BACKGROUND
Line manager (LM) training in mental health is gaining recognition as an effective method for improving the mental health and wellbeing of workers. However, research predominantly focuses on the impacts of training at the employee-level, often neglecting the broader organisational-level outcomes. Most studies derive insights from LMs using self-reported data, with very few studies examining impacts on organisational-level outcomes.
AIM OBJECTIVE
To explore the relationship between LM training in mental health and organisational-level outcomes using company-level data from a diverse range of organisations.
METHODS METHODS
This study is a secondary analysis of anonymised panel survey data from firms in England, with data derived from computer-assisted telephone surveys over four waves (2020, 1899 firms; 2021, 1551; 2022, 1904; and 2023, 1902). The analysis merged the four datasets to control for temporal variations. Probit regression was conducted including controls for age of organisation, sector, size, and wave to isolate specific relationships of interest.
RESULTS RESULTS
We found that LM training in mental health is significantly associated with several organisational-level outcomes, including: improved staff recruitment (β = .317, p < .001) and retention (β = .453, p < .001), customer service (β = .453, p < .001), business performance (β = .349, p < .001), and lower long-term sickness absence due to mental ill-health (β = -.132, p < .05).
CONCLUSION CONCLUSIONS
This is the first study to explore the organisational-level outcomes of LM training in mental health in a large sample of organisations of different types, sizes, and sectors. Training LM in mental health is directly related to diverse aspects of an organisations' functioning and, therefore, has strategic business value for organisations. This knowledge has international relevance for policy and practice in workforce health and business performance.

Identifiants

pubmed: 39018274
doi: 10.1371/journal.pone.0306065
pii: PONE-D-24-06886
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0306065

Informations de copyright

Copyright: © 2024 Hassard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Juliet Hassard (J)

Queen's Business School, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.

Teixiera Dulal-Arthur (T)

School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Jane Bourke (J)

Cork University Business School, University College Cork, Cork, Ireland.

Maria Wishart (M)

Warwick Business School, Warwick University, Coventry, United Kingdom.

Stephen Roper (S)

Warwick Business School, Warwick University, Coventry, United Kingdom.

Vicki Belt (V)

Warwick Business School, Warwick University, Coventry, United Kingdom.

Stavroula Leka (S)

Centre for Organisational Health & Well-being, Lancaster University, Lancaster, United Kingdom.

Nick Pahl (N)

The Society of Occupational Medicine, London, United Kingdom.

Craig Bartle (C)

School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Louise Thomson (L)

School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom.

Holly Blake (H)

School of Health Sciences, University of Nottingham, Nottingham, United Kingdom.
NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH